⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1482882 | 0.95 | — | — | |
| SCHEMBL9302132 | 0.92 | CES2 (0.56) | — | |
| SCHEMBL3281327 | 0.92 | CES2 (0.56) | — | |
| SCHEMBL76487 | 0.92 | CES2 (0.56) | — | |
| SCHEMBL4621525 | 0.92 | CES2 (0.56) | — | |
| SCHEMBL1679337 | 0.92 | CES2 (0.56) | — | |
| SCHEMBL5925480 | 0.92 | CES2 (0.56) | — | |
| SCHEMBL42694 | 0.85 | — | — | |
| SCHEMBL543757 | 0.82 | CES1 (0.55) | — | |
| SCHEMBL817806 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143408-B2 | N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | ASTRAZENECA AB (SE) | 2012-03-27 | — | — | US | claimed |
| US-20100137322-A1 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2010-06-03 | — | — | US | claimed |
| EP-2158198-A2 | NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | AstraZeneca AB (SE) | 2010-03-03 | — | — | EP | claimed |
| WO-2008130320-A2 | NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | claimed |
| EP-0673928-B1 | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | SANOFI SYNTHELABO (FR) | 2001-08-29 | — | — | EP | claimed |
| EP-0321556-A4 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | — | 1991-06-12 | — | — | EP | claimed |
| US-4880811-A | SIDE EFFECT REDUCTION; NONSEDATING; GOUT; ANTIARTHRITIC AGENTS; METABOLIC, BLOOD AND GENETIC DISORDERS | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1989-11-14 | — | — | US | claimed |
| EP-0321556-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | Memorial Hospital for Cancer and Allied Diseases (US) | 1989-06-28 | — | — | EP | claimed |
| WO-1988010114-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1988-12-29 | — | — | WO | claimed |
| CN-115667259-A | Condensed ring compounds for inhibiting H-PGDS | 佐藤制药株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-104969406-A | Electrolyte solution for electrochemical device and electrochemical device | WAKO PURE CHEM IND LTD | 2015-10-07 | — | — | CN | disclosed |
| EP-1717230-B1 | FUSED-RING 4-OXOPYRIMIDINE DERIVATIVE | MSD KK (JP) | 2014-08-06 | — | — | EP | disclosed |
| EP-1932841-B1 | SULFONAMIDE COMPOUND | ASAHI KASEI PHARMA CORP (JP) | 2014-01-01 | — | — | EP | disclosed |
| US-8415372-B2 | Sulfonamide compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2013-04-09 | — | — | US | disclosed |
| EP-0392317-A2 | Benzimidazoles, drugs containing these compounds and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1990-10-17 | — | — | EP | disclosed |
| US-4880811-A | SIDE EFFECT REDUCTION; NONSEDATING; GOUT; ANTIARTHRITIC AGENTS; METABOLIC, BLOOD AND GENETIC DISORDERS | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1989-11-14 | — | — | US | disclosed |
| EP-0321556-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | Memorial Hospital for Cancer and Allied Diseases (US) | 1989-06-28 | — | — | EP | disclosed |
| WO-1988010114-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1988-12-29 | — | — | WO | disclosed |
| US-4616015-A | HYPOTENSIVE AGENT, ANTULCER AGENT, ANTICOAGULANT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-10-07 | — | — | US | disclosed |
| EP-0122627-A2 | Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-24 | — | — | EP | disclosed |